Steven Kafka - Foundation Medicine Pres and COO

COO

Dr. Steven Kafka, Ph.D., is no longer President, Chief Operating Officer of Foundation Medicine, Inc., effective February 16, 2018 Dr. Kafka was previously chief operating officer and chief financial officer at Aileron Therapeutics Inc., a biopharmaceutical company based in Cambridge, Massachusetts from September 2009 to October 2012. Before Aileron, from September 2006 to September 2009, Dr. Kafka was vice president of finance at Infinity Pharmaceuticals, Inc., a drug discovery and development company
Age 46
Professional MarksPh.D
Phone617 418-2200
Webwww.foundationmedicine.com
Kafka earned his B.A. from Stanford University and his Ph.D. from Harvard University.

Foundation Medicine Management Efficiency

Foundation Medicine's management efficiency ratios could be used to measure how well Foundation Medicine manages its routine affairs as well as how well it operates its assets and liabilities.
The company has 90 M in debt with debt to equity (D/E) ratio of 476.2, demonstrating that the company may be unable to create cash to meet all of its financial commitments. Foundation Medicine has a current ratio of 2.22, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Foundation Medicine until it has trouble settling it off, either with new capital or with free cash flow. So, Foundation Medicine's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Foundation Medicine sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Foundation to invest in growth at high rates of return. When we think about Foundation Medicine's use of debt, we should always consider it together with cash and equity.
Foundation Medicine, Inc. provides various molecular information products in the United States. Foundation Medicine, Inc. is a subsidiary of Roche Holdings, Inc. Foundation Medicine operates under Diagnostics Research classification in USA and traded on NASDAQ. It employs 662 people. Foundation Medicine (FMI) is traded on NASDAQ Exchange in USA and employs 662 people.

Management Performance

Foundation Medicine Leadership Team

Elected by the shareholders, the Foundation Medicine's board of directors comprises two types of representatives: Foundation Medicine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Foundation. The board's role is to monitor Foundation Medicine's management team and ensure that shareholders' interests are well served. Foundation Medicine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Foundation Medicine's outside directors are responsible for providing unbiased perspectives on the board's policies.
Daniel Day, Director
Michael Varney, Director
Krishna Yeshwant, Independent Director
David Daly, Chief Commercial Officer
David Schenkein, Independent Director
Melanie Nallicheri, Chief business Officer and head of Biopharma
Alexis Borisy, Chairman of the Board, Co-Founder
Steven Kafka, Pres and COO
Evan Jones, Independent Director
Vincent Miller, Chief Medical Officer
Konstantin Fiedler, COO
Michael Pellini, President CEO, Director
Robert Hesslein, Senior Vice President General Counsel
Sandra Horning, Director
Michael Doherty, Head of Product Development
Jason Ryan, CFO
Michael Dougherty, Director
Tom Civik, Chief Commercial Officer
Troy Cox, CEO, Director
Thomas Civik, Chief Commercial Officer

Foundation Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Foundation Medicine a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Foundation Medicine in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Foundation Medicine's short interest history, or implied volatility extrapolated from Foundation Medicine options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Consideration for investing in Foundation Stock

If you are still planning to invest in Foundation Medicine check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Foundation Medicine's history and understand the potential risks before investing.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Money Managers
Screen money managers from public funds and ETFs managed around the world
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
CEOs Directory
Screen CEOs from public companies around the world
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas